首页> 外国专利> BIO-MARKER FOR PREDICTING AIRWAY RESPONSIVENESS OF ICS IN THE ASTHMATIC PATIENTS INCLUDING TAAR6 POLYMORPHISMS RS7772821 AND THE DIAGNOSING KIT INCLUDING THE SAME

BIO-MARKER FOR PREDICTING AIRWAY RESPONSIVENESS OF ICS IN THE ASTHMATIC PATIENTS INCLUDING TAAR6 POLYMORPHISMS RS7772821 AND THE DIAGNOSING KIT INCLUDING THE SAME

机译:在包括Taar6多态性RS7772821和诊断工具包在内的哮喘患者中预测ICS气道反应的生物标记

摘要

The present invention relates to biomarkers for predicting airway responsiveness to inhaled corticosteroids in asthmatic patients with rs7772821TG polynucleotide in a TAAR6 gene and a disgnostic kit including the same and, more specifically, to biomarkers comprising rs7772821TG polynucleotide or complementary polynucleotide thereof in a TAAR6 gene to predict the fact that airway responsiveness is increased when administrating inhaled corticosteroids to asthmatic patients, and to a diagnostic kit including the biomarkers. The present invention provides biomarkers for predicting airway responsiveness to inhaled corticosteroids in asthmatic patients, comprising rs7772821TG polynucleotide or complementary polynucleotide thereof in a TAAR6 gene. In addition, the present invention provides a diagnostic kit for predicting airway responsiveness to inhaled corticosteroids in asthmatic patients, comprising one or more of the biomarkers.
机译:本发明涉及用于预测具有TAAR6基因中的rs7772821T> G多核苷酸的哮喘患者的气道患者对吸入的皮质类固醇的气道反应性的生物标志物,以及包括该标志物的诊断试剂盒,更具体地,涉及一种生物标志物,其包含一种TAAR6基因可预测以下事实:向哮喘患者和包括生物标记物的诊断试剂盒服用吸入皮质类固醇激素时,气道反应性会增加。本发明提供了用于预测哮喘患者中对吸入的皮质类固醇的气道反应性的生物标志物,其在TAAR6基因中包含rs7772821T> G多核苷酸或其互补多核苷酸。另外,本发明提供了用于预测哮喘患者中对吸入的皮质类固醇的气道反应性的诊断试剂盒,其包含一种或多种生物标记。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号